Your browser (Internet Explorer 7 or lower) is out of date. It has known security flaws and may not display all features of this and other websites. Learn how to update your browser.


Biotechnology and Life Sciences Technologies Available for Licensing

Thse are some of the technologies available from the University of Auckland through UniServices. 

Remember with UniServices if you pay for it, you own it, the IP will be assigned to you. 

New Case Studies

  • Formus - Intelligent, real-time and collaborative custom prosthesis design solutions.

ACID (automatic custom implant design) from Formus Labs is an intelligent custom design platform presented as a webservice that allows engineers and surgeons to collaboratively view and modify prosthesis designs in real time.

A novel topical drug delivery system that could overcome the limitations of current treatments. Niosomes have unique properties for enhanced drug penetration, sustained drug release and an ability to carry both hydrophilic and lipophilic drugs.


Researchers from The University of Auckland have developed a novel collagen based scaffold that may be used as a corneal tissue substitute for transplantation that could overcome the limitations of current treatments.

Combining the technology’s novel image processing and head stabilisation algorithms with a visual stimulus display system; we are able to rapidly and objectively assess visual function in young children.

Increasing shelf life, while maintaining important consumer satisfaction traits including freshness, taste and quality, and with no requirement for additives or preservatives.

Azo Carbonamide Carboxylates are a family of compounds able to substitute the common but inconvenient reagents in the widely used Mitsunobu reaction.

Complex wine aroma prediction model for accurate blending, allowing the development of highly consistent flavours.

Short-acting ketamine analogues with reduced adverse effect profiles are being developed for use in anaesthesia.

A cell penetrating peptide that enables delivery of functional molecules into cells that are otherwise not cell permeable

Developing a first in class small molecule inhibitors of perforin, to develop novel therapeutics for a range of auto-immune and infectious diseases.

An interactive gaming system that trains tinnitus sufferers to not hear the ringing in their ears


Current Technology in Development

Find descriptions of current projects accross Biotechnology and Life Sciences below. Please contact our Commercialisation Managers for any License, partner or commercial enquiries by clicking the project name.

Pelvic Floor Pressure sensor

Development of a new vaginal pressure sensor which will allow concurrent measurement of abdominal and pelvic floor muscle activity. It will also enable measurement of where the pressure changes occur along the length of the vagina which will add to our understanding of how this change might influence the development of pelvic floor muscle disorders such as incontinence and pelvic organ prolapse. 


Keratoconus is an eye disease in which thinning and weakening of the cornea results in loss of vision. It is a non-inflammatory eye condition in which the normally round dome-shaped cornea progressively thins causing a cone-like bulge to develop. Keratoconus occurs in 1 in 2000 people worldwide and results in a large number of corneal transplants. Researchers from the University of Auckland Department of Ophthalmology have developed a topical eye formula to treat and reverse the symptoms of Keratoconus without the need for invasive ocular surgery. Preclinical ex-vivo large animal studies have shown efficacy of the formulation in reprogramming stromal keratoncyes to deposit new non-scarring collagen. A PCT has been filed and peer reviewed journal articles are available for review.

Ketamine Analogue

Ketamine is an anaesthetic which has enjoyed only limited use due to its low rate of metabolism and hallucinogenic effects.  We have surprisingly discovered that the structure of ketamine can be modified to increase the rate of metabolism while retaining its efficacy as an anaethetic.  While the hallucinogenic effects remain, they are clinically acceptable where they occur over a shorter period.   

Actigaze - Gaze Control Algorithm

Actigaze software technology using entirely gaze-based selection rivals the performance of traditional input devices while overcoming the inherent problems of gaze-based click alternatives in the market place. Actigaze technology presents a complete replacement for a mouse or touchscreen input.           

Formus - Designing an acetabular reconstruction implant

Formus delivers intelligent custom design workflows presented as a webservice that allows engineers and surgeons to collaboratively view and modify custom implant designs in real time, reducing design time from 35 to 5 hours. The result is a more robust implant for the patient, higher satisfaction rates for the surgeon, and cost savings and scalability for the custom implant provider.